# Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

> **NCT06027892** · NA · RECRUITING · sponsor: **Rabin Medical Center** · enrollment: 562 (estimated)

## Conditions studied

- PROSTATE CANCER

## Interventions

- **RADIATION:** Two-fraction stereotactic radiotherapy
- **RADIATION:** Five-fraction stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT06027892
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-29
- **Primary completion:** 2027-12
- **Final completion:** 2032-12
- **Target enrollment:** 562 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06027892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06027892, "Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06027892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*